142 related articles for article (PubMed ID: 31739256)
1. Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infection.
Khadir F; Taheri T; Habibzadeh S; Zahedifard F; Gholami E; Heidari-Kharaji M; Oryan A; Rafati S
Vet Parasitol; 2019 Dec; 276():108976. PubMed ID: 31739256
[TBL] [Abstract][Full Text] [Related]
2. Comparison of
Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
[TBL] [Abstract][Full Text] [Related]
3. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
Hadighi R; Mohebali M; Boucher P; Hajjaran H; Khamesipour A; Ouellette M
PLoS Med; 2006 May; 3(5):e162. PubMed ID: 16605301
[TBL] [Abstract][Full Text] [Related]
4. The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling.
Oliaee RT; Sharifi I; Bamorovat M; Keyhani A; Babaei Z; Salarkia E; Tavakoly R; Khosravi A; Mostafavi M; Sharifi F; Mousavi SM
Int Immunopharmacol; 2020 Sep; 86():106704. PubMed ID: 32590317
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
Bemani E; Oryan A; Bahrami S
Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
[TBL] [Abstract][Full Text] [Related]
6. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.
Shokri A; Sharifi I; Khamesipour A; Nakhaee N; Fasihi Harandi M; Nosratabadi J; Hakimi Parizi M; Barati M
Parasitol Res; 2012 Mar; 110(3):1113-7. PubMed ID: 21847598
[TBL] [Abstract][Full Text] [Related]
7. Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects.
Mostafavi M; Sharifi I; Farajzadeh S; Khazaeli P; Sharifi H; Pourseyedi E; Kakooei S; Bamorovat M; Keyhani A; Parizi MH; Khosravi A; Khamesipour A
Biomed Pharmacother; 2019 Aug; 116():108942. PubMed ID: 31152929
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
9. A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models.
Bamorovat M; Sharifi I; Fekri A; Keyhani A; Aflatoonian MR; Heshmatkhah A; Oliaee RT; Khosravi A; Naderi A; Parizi MH; Mostafavi M; Varma RS
Microb Pathog; 2019 Mar; 128():162-170. PubMed ID: 30583021
[TBL] [Abstract][Full Text] [Related]
10. The potential therapeutic role of PTR1 gene in non-healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica.
Sezavar M; Sharifi I; Ghasemi Nejad Almani P; Kazemi B; Davoudi N; Salari S; Salarkia E; Khosravi A; Bamorovat M
J Clin Lab Anal; 2021 Mar; 35(3):e23670. PubMed ID: 33283321
[TBL] [Abstract][Full Text] [Related]
11. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
[TBL] [Abstract][Full Text] [Related]
12. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations.
Abamor ES; Allahverdiyev AM
Exp Parasitol; 2016 Jul; 166():150-63. PubMed ID: 27109311
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of meglumine antimoniate against L. tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran.
Karamian M; Bojd MS; Salehabadi A; Hemmati M; Barati DA
East Mediterr Health J; 2015 Jun; 21(4):280-6. PubMed ID: 26077523
[TBL] [Abstract][Full Text] [Related]
14. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
Hadighi R; Boucher P; Khamesipour A; Meamar AR; Roy G; Ouellette M; Mohebali M
Parasitol Res; 2007 Oct; 101(5):1319-22. PubMed ID: 17610079
[TBL] [Abstract][Full Text] [Related]
15. A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica.
Mostafavi M; Khazaeli P; Sharifi I; Farajzadeh S; Sharifi H; Keyhani A; Parizi MH; Kakooei S
Korean J Parasitol; 2019 Feb; 57(1):1-8. PubMed ID: 30840792
[TBL] [Abstract][Full Text] [Related]
16. Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro.
Allahverdiyev AM; Abamor ES; Bagirova M; Baydar SY; Ates SC; Kaya F; Kaya C; Rafailovich M
Exp Parasitol; 2013 Sep; 135(1):55-63. PubMed ID: 23792003
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Antileishmanial Activities of Pistacia vera Essential Oil.
Mahmoudvand H; Saedi Dezaki E; Ezatpour B; Sharifi I; Kheirandish F; Rashidipour M
Planta Med; 2016 Mar; 82(4):279-84. PubMed ID: 26829519
[TBL] [Abstract][Full Text] [Related]
18. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
[TBL] [Abstract][Full Text] [Related]
20. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
Moosavian SA; Fallah M; Jaafari MR
Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]